Antimicrobial Resistance Diagnostics Market

Global Antimicrobial Resistance Diagnostics Market Size, Share & Industry Trends Analysis Report By Technology, By End User (Hospitals, Diagnostic Laboratories and Pharmaceutical, Biotechnology Companies), By Pathogen, By Regional Outlook and Forecast, 2022 - 2028

Report Id: KBV-12211 Publication Date: November-2022 Number of Pages: 288
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Antimicrobial Resistance Diagnostics Market, by Technology
1.4.2 Global Antimicrobial Resistance Diagnostics Market, by End User
1.4.3 Global Antimicrobial Resistance Diagnostics Market, by Pathogen
1.4.4 Global Antimicrobial Resistance Diagnostics Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)

Chapter 4. Global Antimicrobial Resistance Diagnostics Market by Technology
4.1 Global PCR Market by Region
4.2 Global Immunoassay Market by Region
4.3 Global NGS Market by Region
4.4 Global Microbiology Culture Market by Region
4.5 Global Mass Spectrometry Market by Region
4.6 Global Rapid & Point of Care Market by Region
4.7 Global Others Market by Region

Chapter 5. Global Antimicrobial Resistance Diagnostics Market by End-user
5.1 Global Hospitals Market by Region
5.2 Global Diagnostic Laboratories Market by Region
5.3 Global Pharmaceutical, Biotechnology Companies & Others Market by Region

Chapter 6. Global Antimicrobial Resistance Diagnostics Market by Pathogen
6.1 Global Methicillin Resistant Staphylococcus Aureus (MRSA) Market by Region
6.2 Global Clostridium Difficile (CD) Market by Region
6.3 Global Drug Resistant Campylobacter (DRC) Market by Region
6.4 Global Drug Resistant Streptococcus Pneumoniae (DRSP) Market by Region
6.5 Global Drug Resistant Neisseria Gonorrhoeae (DRNG) Market by Region
6.6 Global Drug Resistant Salmonella (DRNTS) Market by Region
6.7 Global Others Market by Region

Chapter 7. Global Antimicrobial Resistance Diagnostics Market by Region
7.1 North America Antimicrobial Resistance Diagnostics Market
7.1.1 North America Antimicrobial Resistance Diagnostics Market by Technology
7.1.1.1 North America PCR Market by Country
7.1.1.2 North America Immunoassay Market by Country
7.1.1.3 North America NGS Market by Country
7.1.1.4 North America Microbiology Culture Market by Country
7.1.1.5 North America Mass Spectrometry Market by Country
7.1.1.6 North America Rapid & Point of Care Market by Country
7.1.1.7 North America Others Market by Country
7.1.2 North America Antimicrobial Resistance Diagnostics Market by End-user
7.1.2.1 North America Hospitals Market by Country
7.1.2.2 North America Diagnostic Laboratories Market by Country
7.1.2.3 North America Pharmaceutical, Biotechnology Companies & Others Market by Country
7.1.3 North America Antimicrobial Resistance Diagnostics Market by Pathogen
7.1.3.1 North America Methicillin Resistant Staphylococcus Aureus (MRSA) Market by Country
7.1.3.2 North America Clostridium Difficile (CD) Market by Country
7.1.3.3 North America Drug Resistant Campylobacter (DRC) Market by Country
7.1.3.4 North America Drug Resistant Streptococcus Pneumoniae (DRSP) Market by Country
7.1.3.5 North America Drug Resistant Neisseria Gonorrhoeae (DRNG) Market by Country
7.1.3.6 North America Drug Resistant Salmonella (DRNTS) Market by Country
7.1.3.7 North America Others Market by Country
7.1.4 North America Antimicrobial Resistance Diagnostics Market by Country
7.1.4.1 US Antimicrobial Resistance Diagnostics Market
7.1.4.1.1 US Antimicrobial Resistance Diagnostics Market by Technology
7.1.4.1.2 US Antimicrobial Resistance Diagnostics Market by End-user
7.1.4.1.3 US Antimicrobial Resistance Diagnostics Market by Pathogen
7.1.4.2 Canada Antimicrobial Resistance Diagnostics Market
7.1.4.2.1 Canada Antimicrobial Resistance Diagnostics Market by Technology
7.1.4.2.2 Canada Antimicrobial Resistance Diagnostics Market by End-user
7.1.4.2.3 Canada Antimicrobial Resistance Diagnostics Market by Pathogen
7.1.4.3 Mexico Antimicrobial Resistance Diagnostics Market
7.1.4.3.1 Mexico Antimicrobial Resistance Diagnostics Market by Technology
7.1.4.3.2 Mexico Antimicrobial Resistance Diagnostics Market by End-user
7.1.4.3.3 Mexico Antimicrobial Resistance Diagnostics Market by Pathogen
7.1.4.4 Rest of North America Antimicrobial Resistance Diagnostics Market
7.1.4.4.1 Rest of North America Antimicrobial Resistance Diagnostics Market by Technology
7.1.4.4.2 Rest of North America Antimicrobial Resistance Diagnostics Market by End-user
7.1.4.4.3 Rest of North America Antimicrobial Resistance Diagnostics Market by Pathogen
7.2 Europe Antimicrobial Resistance Diagnostics Market
7.2.1 Europe Antimicrobial Resistance Diagnostics Market by Technology
7.2.1.1 Europe PCR Market by Country
7.2.1.2 Europe Immunoassay Market by Country
7.2.1.3 Europe NGS Market by Country
7.2.1.4 Europe Microbiology Culture Market by Country
7.2.1.5 Europe Mass Spectrometry Market by Country
7.2.1.6 Europe Rapid & Point of Care Market by Country
7.2.1.7 Europe Others Market by Country
7.2.2 Europe Antimicrobial Resistance Diagnostics Market by End-user
7.2.2.1 Europe Hospitals Market by Country
7.2.2.2 Europe Diagnostic Laboratories Market by Country
7.2.2.3 Europe Pharmaceutical, Biotechnology Companies & Others Market by Country
7.2.3 Europe Antimicrobial Resistance Diagnostics Market by Pathogen
7.2.3.1 Europe Methicillin Resistant Staphylococcus Aureus (MRSA) Market by Country
7.2.3.2 Europe Clostridium Difficile (CD) Market by Country
7.2.3.3 Europe Drug Resistant Campylobacter (DRC) Market by Country
7.2.3.4 Europe Drug Resistant Streptococcus Pneumoniae (DRSP) Market by Country
7.2.3.5 Europe Drug Resistant Neisseria Gonorrhoeae (DRNG) Market by Country
7.2.3.6 Europe Drug Resistant Salmonella (DRNTS) Market by Country
7.2.3.7 Europe Others Market by Country
7.2.4 Europe Antimicrobial Resistance Diagnostics Market by Country
7.2.4.1 Germany Antimicrobial Resistance Diagnostics Market
7.2.4.1.1 Germany Antimicrobial Resistance Diagnostics Market by Technology
7.2.4.1.2 Germany Antimicrobial Resistance Diagnostics Market by End-user
7.2.4.1.3 Germany Antimicrobial Resistance Diagnostics Market by Pathogen
7.2.4.2 UK Antimicrobial Resistance Diagnostics Market
7.2.4.2.1 UK Antimicrobial Resistance Diagnostics Market by Technology
7.2.4.2.2 UK Antimicrobial Resistance Diagnostics Market by End-user
7.2.4.2.3 UK Antimicrobial Resistance Diagnostics Market by Pathogen
7.2.4.3 France Antimicrobial Resistance Diagnostics Market
7.2.4.3.1 France Antimicrobial Resistance Diagnostics Market by Technology
7.2.4.3.2 France Antimicrobial Resistance Diagnostics Market by End-user
7.2.4.3.3 France Antimicrobial Resistance Diagnostics Market by Pathogen
7.2.4.4 Russia Antimicrobial Resistance Diagnostics Market
7.2.4.4.1 Russia Antimicrobial Resistance Diagnostics Market by Technology
7.2.4.4.2 Russia Antimicrobial Resistance Diagnostics Market by End-user
7.2.4.4.3 Russia Antimicrobial Resistance Diagnostics Market by Pathogen
7.2.4.5 Spain Antimicrobial Resistance Diagnostics Market
7.2.4.5.1 Spain Antimicrobial Resistance Diagnostics Market by Technology
7.2.4.5.2 Spain Antimicrobial Resistance Diagnostics Market by End-user
7.2.4.5.3 Spain Antimicrobial Resistance Diagnostics Market by Pathogen
7.2.4.6 Italy Antimicrobial Resistance Diagnostics Market
7.2.4.6.1 Italy Antimicrobial Resistance Diagnostics Market by Technology
7.2.4.6.2 Italy Antimicrobial Resistance Diagnostics Market by End-user
7.2.4.6.3 Italy Antimicrobial Resistance Diagnostics Market by Pathogen
7.2.4.7 Rest of Europe Antimicrobial Resistance Diagnostics Market
7.2.4.7.1 Rest of Europe Antimicrobial Resistance Diagnostics Market by Technology
7.2.4.7.2 Rest of Europe Antimicrobial Resistance Diagnostics Market by End-user
7.2.4.7.3 Rest of Europe Antimicrobial Resistance Diagnostics Market by Pathogen
7.3 Asia Pacific Antimicrobial Resistance Diagnostics Market
7.3.1 Asia Pacific Antimicrobial Resistance Diagnostics Market by Technology
7.3.1.1 Asia Pacific PCR Market by Country
7.3.1.2 Asia Pacific Immunoassay Market by Country
7.3.1.3 Asia Pacific NGS Market by Country
7.3.1.4 Asia Pacific Microbiology Culture Market by Country
7.3.1.5 Asia Pacific Mass Spectrometry Market by Country
7.3.1.6 Asia Pacific Rapid & Point of Care Market by Country
7.3.1.7 Asia Pacific Others Market by Country
7.3.2 Asia Pacific Antimicrobial Resistance Diagnostics Market by End-user
7.3.2.1 Asia Pacific Hospitals Market by Country
7.3.2.2 Asia Pacific Diagnostic Laboratories Market by Country
7.3.2.3 Asia Pacific Pharmaceutical, Biotechnology Companies & Others Market by Country
7.3.3 Asia Pacific Antimicrobial Resistance Diagnostics Market by Pathogen
7.3.3.1 Asia Pacific Methicillin Resistant Staphylococcus Aureus (MRSA) Market by Country
7.3.3.2 Asia Pacific Clostridium Difficile (CD) Market by Country
7.3.3.3 Asia Pacific Drug Resistant Campylobacter (DRC) Market by Country
7.3.3.4 Asia Pacific Drug Resistant Streptococcus Pneumoniae (DRSP) Market by Country
7.3.3.5 Asia Pacific Drug Resistant Neisseria Gonorrhoeae (DRNG) Market by Country
7.3.3.6 Asia Pacific Drug Resistant Salmonella (DRNTS) Market by Country
7.3.3.7 Asia Pacific Others Market by Country
7.3.4 Asia Pacific Antimicrobial Resistance Diagnostics Market by Country
7.3.4.1 China Antimicrobial Resistance Diagnostics Market
7.3.4.1.1 China Antimicrobial Resistance Diagnostics Market by Technology
7.3.4.1.2 China Antimicrobial Resistance Diagnostics Market by End-user
7.3.4.1.3 China Antimicrobial Resistance Diagnostics Market by Pathogen
7.3.4.2 Japan Antimicrobial Resistance Diagnostics Market
7.3.4.2.1 Japan Antimicrobial Resistance Diagnostics Market by Technology
7.3.4.2.2 Japan Antimicrobial Resistance Diagnostics Market by End-user
7.3.4.2.3 Japan Antimicrobial Resistance Diagnostics Market by Pathogen
7.3.4.3 India Antimicrobial Resistance Diagnostics Market
7.3.4.3.1 India Antimicrobial Resistance Diagnostics Market by Technology
7.3.4.3.2 India Antimicrobial Resistance Diagnostics Market by End-user
7.3.4.3.3 India Antimicrobial Resistance Diagnostics Market by Pathogen
7.3.4.4 South Korea Antimicrobial Resistance Diagnostics Market
7.3.4.4.1 South Korea Antimicrobial Resistance Diagnostics Market by Technology
7.3.4.4.2 South Korea Antimicrobial Resistance Diagnostics Market by End-user
7.3.4.4.3 South Korea Antimicrobial Resistance Diagnostics Market by Pathogen
7.3.4.5 Singapore Antimicrobial Resistance Diagnostics Market
7.3.4.5.1 Singapore Antimicrobial Resistance Diagnostics Market by Technology
7.3.4.5.2 Singapore Antimicrobial Resistance Diagnostics Market by End-user
7.3.4.5.3 Singapore Antimicrobial Resistance Diagnostics Market by Pathogen
7.3.4.6 Malaysia Antimicrobial Resistance Diagnostics Market
7.3.4.6.1 Malaysia Antimicrobial Resistance Diagnostics Market by Technology
7.3.4.6.2 Malaysia Antimicrobial Resistance Diagnostics Market by End-user
7.3.4.6.3 Malaysia Antimicrobial Resistance Diagnostics Market by Pathogen
7.3.4.7 Rest of Asia Pacific Antimicrobial Resistance Diagnostics Market
7.3.4.7.1 Rest of Asia Pacific Antimicrobial Resistance Diagnostics Market by Technology
7.3.4.7.2 Rest of Asia Pacific Antimicrobial Resistance Diagnostics Market by End-user
7.3.4.7.3 Rest of Asia Pacific Antimicrobial Resistance Diagnostics Market by Pathogen
7.4 LAMEA Antimicrobial Resistance Diagnostics Market
7.4.1 LAMEA Antimicrobial Resistance Diagnostics Market by Technology
7.4.1.1 LAMEA PCR Market by Country
7.4.1.2 LAMEA Immunoassay Market by Country
7.4.1.3 LAMEA NGS Market by Country
7.4.1.4 LAMEA Microbiology Culture Market by Country
7.4.1.5 LAMEA Mass Spectrometry Market by Country
7.4.1.6 LAMEA Rapid & Point of Care Market by Country
7.4.1.7 LAMEA Others Market by Country
7.4.2 LAMEA Antimicrobial Resistance Diagnostics Market by End-user
7.4.2.1 LAMEA Hospitals Market by Country
7.4.2.2 LAMEA Diagnostic Laboratories Market by Country
7.4.2.3 LAMEA Pharmaceutical, Biotechnology Companies & Others Market by Country
7.4.3 LAMEA Antimicrobial Resistance Diagnostics Market by Pathogen
7.4.3.1 LAMEA Methicillin Resistant Staphylococcus Aureus (MRSA) Market by Country
7.4.3.2 LAMEA Clostridium Difficile (CD) Market by Country
7.4.3.3 LAMEA Drug Resistant Campylobacter (DRC) Market by Country
7.4.3.4 LAMEA Drug Resistant Streptococcus Pneumoniae (DRSP) Market by Country
7.4.3.5 LAMEA Drug Resistant Neisseria Gonorrhoeae (DRNG) Market by Country
7.4.3.6 LAMEA Drug Resistant Salmonella (DRNTS) Market by Country
7.4.3.7 LAMEA Others Market by Country
7.4.4 LAMEA Antimicrobial Resistance Diagnostics Market by Country
7.4.4.1 Brazil Antimicrobial Resistance Diagnostics Market
7.4.4.1.1 Brazil Antimicrobial Resistance Diagnostics Market by Technology
7.4.4.1.2 Brazil Antimicrobial Resistance Diagnostics Market by End-user
7.4.4.1.3 Brazil Antimicrobial Resistance Diagnostics Market by Pathogen
7.4.4.2 Argentina Antimicrobial Resistance Diagnostics Market
7.4.4.2.1 Argentina Antimicrobial Resistance Diagnostics Market by Technology
7.4.4.2.2 Argentina Antimicrobial Resistance Diagnostics Market by End-user
7.4.4.2.3 Argentina Antimicrobial Resistance Diagnostics Market by Pathogen
7.4.4.3 UAE Antimicrobial Resistance Diagnostics Market
7.4.4.3.1 UAE Antimicrobial Resistance Diagnostics Market by Technology
7.4.4.3.2 UAE Antimicrobial Resistance Diagnostics Market by End-user
7.4.4.3.3 UAE Antimicrobial Resistance Diagnostics Market by Pathogen
7.4.4.4 Saudi Arabia Antimicrobial Resistance Diagnostics Market
7.4.4.4.1 Saudi Arabia Antimicrobial Resistance Diagnostics Market by Technology
7.4.4.4.2 Saudi Arabia Antimicrobial Resistance Diagnostics Market by End-user
7.4.4.4.3 Saudi Arabia Antimicrobial Resistance Diagnostics Market by Pathogen
7.4.4.5 South Africa Antimicrobial Resistance Diagnostics Market
7.4.4.5.1 South Africa Antimicrobial Resistance Diagnostics Market by Technology
7.4.4.5.2 South Africa Antimicrobial Resistance Diagnostics Market by End-user
7.4.4.5.3 South Africa Antimicrobial Resistance Diagnostics Market by Pathogen
7.4.4.6 Nigeria Antimicrobial Resistance Diagnostics Market
7.4.4.6.1 Nigeria Antimicrobial Resistance Diagnostics Market by Technology
7.4.4.6.2 Nigeria Antimicrobial Resistance Diagnostics Market by End-user
7.4.4.6.3 Nigeria Antimicrobial Resistance Diagnostics Market by Pathogen
7.4.4.7 Rest of LAMEA Antimicrobial Resistance Diagnostics Market
7.4.4.7.1 Rest of LAMEA Antimicrobial Resistance Diagnostics Market by Technology
7.4.4.7.2 Rest of LAMEA Antimicrobial Resistance Diagnostics Market by End-user
7.4.4.7.3 Rest of LAMEA Antimicrobial Resistance Diagnostics Market by Pathogen

Chapter 8. Company Profiles
8.1 Abbott Laboratories
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 Becton, Dickinson and Company
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 BioMérieux S.A.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition, Joint Ventures and Mergers:
8.4 F. Hoffmann-La Roche Ltd.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Acquisition and Mergers:
8.5 Danaher Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Acquisition and Mergers:
8.6 Hologic, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Financial Analysis
8.6.4 Segmental and Regional Analysis
8.6.5 Recent strategies and developments:
8.6.5.1 Product Launches and Product Expansions:
8.6.5.2 Acquisition and Mergers:
8.7 Vela Diagnostics Pte. Ltd. (Luye Medical Group Co., Ltd)
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Product Launches and Product Expansions:
8.8 Molsid SAS
8.8.1 Company Overview
8.9 Visby Medical, Inc.
8.9.1 Company Overview
8.10. Accelerated Technology Laboratories, Inc.
8.10.1 Company Overview
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo